Update on the Use of Antihypertensive Drugs in Pregnancy
- 1 April 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 51 (4), 960-969
- https://doi.org/10.1161/hypertensionaha.106.075895
Abstract
S the most common medical disorder of pregnancy, hyper- tension is reported to complicate 1 in 10 pregnancies1,2 and affects an estimated 240 000 women in the United States each year.3 Antihypertensive treatment rationale in this group repre- sents a departure from the nonpregnant adult Seventh Report of the Joint National Committee on Prevention, Detection, Evalu- ation, and Treatment of High Blood Pressure guidelines.4 First, during pregnancy, the priority regarding hypertension is in making the correct diagnosis, with the emphasis on distinguish- ing preexisting (chronic) from pregnancy induced (gestational hypertension and the syndrome of preeclampsia). Second, much of the obstetric literature distinguishes blood pressure (BP) levels as either mild (140 to 159/90 to 109 mm Hg) or severe (160/110 mm Hg), rather than as stages (as in Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; Table 1). Third, in contrast to hypertension guidelines in adults, which emphasize the importance of systolic BP, much of the obstetric literature focuses on diastolic rather than systolic BP, in part because of the lack of clinical trials to support one approach versus another. The focus of treatment is the 9 months of pregnancy, during which untreated mild-to-moderate hyperten- sion is unlikely to lead to unfavorable long-term maternal outcomes. In this setting, antihypertensive agents are mainly used to prevent and treat severe hypertension; to prolong pregnancy for as long as safely possible, thereby maximizing the gestational age of the infant; and to minimize fetal exposure to medications that may have adverse effects. During pregnancy, the challenge is in deciding when to use antihypertensive medications and what level of BP to target. The choice of antihypertensive agents is less complex, because only a small proportion of currently available drugs have been adequately evaluated in pregnant women, and many others are contraindi- cated. Appropriate use of antihypertensive drugs in specific pregnancy-associated hypertensive disorders, including thera- peutic BP goals and criteria for selecting specific antihyperten- sive drugs, are discussed in this review.Keywords
This publication has 79 references indexed in Scilit:
- Morbidity and development in childhood of infants born after temporising treatment of early onset pre-eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 2005
- Stroke and Severe Preeclampsia and Eclampsia: A Paradigm Shift Focusing on Systolic Blood PressureObstetrics & Gynecology, 2005
- Postpartum hypertension and nonsteroidal analgesiaAmerican Journal of Obstetrics and Gynecology, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Maternal hypertension and associated pregnancy complications among african-american and other women in the United StatesObstetrics & Gynecology, 1996
- Nitroprusside in preeclampsia. Circulatory distress and paradoxical bradycardia.Hypertension, 1991
- Nifedipine transfer into human milkThe Journal of Pediatrics, 1989
- Drugs in Human MilkClinical Pharmacokinetics, 1988
- Management of hypertension during lactation.Hypertension, 1984